20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

What Is BioGenerator?

BioGenerator is an evergreen investor that creates, grows, and funds innovative companies and talented entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to enabling lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development.

BioGenerator is the investment arm of BioSTL

Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Adarza’s products and services utilize its proprietary Arrayed Imaging Reflectometry™ (“AIR”) detection platform that is capable of rapid identification and quantification and offers key performance benefits in multiplexing, sensitivity, speed, sample size, dynamic range, and ease of use while affording industry-leading low cost. The AIR platform addresses many commercial applications, including disease biomarkers, personalized medicine, drug and vaccine development, allergy, immunology, and infectious diseases research.

Our Companies

The BioGenerator portfolio is a compilation of companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

Our Companies

The BioGenerator portfolio includes companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

Vaccine Breakthrough Published in Nature Communications Highlights Research of Startup VaxNewMo02/21/2019

BioGenerator Company Arch Oncology Doses First Cancer Patient in Phase 1 Clinical Trial02/06/2019

BioGenerator and Bayer Growth Ventures Lead Financing for Agtech Startup CoverCress11/14/2018

BioGenerator Company MediBeacon Granted FDA Breakthrough Status10/22/2018

BioGenerator Company Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy10/10/2018

BioGenerator Company Galera Therapeutics Raises $150 Million to Advance Breakthrough Therapy09/19/2018

BioGenerator Company Benson Hill Biosystems Raises $60 Million Series C led by GV09/10/2018

BioGenerator Company BlueStrata EHR Acquired by Mediware08/01/2018

See All News

What Others Are Saying

Joseph Monahan
Jon Root
Matt Crisp

Stay Updated

Stay up to date with the latest BioGenerator news and details.